Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation
about
Hepatocytes: a key cell type for innate immunityGram-negative marine bacteria: structural features of lipopolysaccharides and their relevance for economically important diseasesSerum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae.Role of glucan and surface protein BAD1 in complement activation by Blastomyces dermatitidis yeast.Pathogen recognition by the long pentraxin PTX3.Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogenPattern recognition by pentraxinsThe "sweet" side of a long pentraxin: how glycosylation affects PTX3 functions in innate immunity and inflammation.Microbial modulation of host immunity with the small molecule phosphorylcholine.The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules.Probiotic Lactobacillus gasseri SBT2055 improves glucose tolerance and reduces body weight gain in rats by stimulating energy expenditure.Anti-pentraxin antibodies in autoimmune systemic diseases: Focus on anti-pentraxin-3 autoantibodies.Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathwayHeterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system.Serum amyloid P-component-mediated inhibition of the uptake of Mycobacterium tuberculosis by macrophages, in vitro.Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer's Disease Brain: A Review.Serum Amyloid P and IgG Exhibit Differential Capabilities in the Activation of the Innate Immune System in Response to Bacillus anthracis Peptidoglycan.Supramolecular amphipathicity for probing antimicrobial propensity of host defence peptides.Modulation of Innate Immune-Related Genes and Glucocorticoid Synthesis in Gnotobiotic Full-Sibling European Sea Bass (Dicentrarchus labrax) Larvae Challenged With Vibrio anguillarum.Invited review: Bacterial lipopolysaccharides and innate immunityThe Pentraxins 1975-2018: Serendipity, Diagnostics and DrugsThe Development of Serum Amyloid P as a Possible Therapeutic
P2860
Q26774699-9542A00F-227F-4B0F-A9A1-21435351C3FFQ27021500-A61CE048-2C5A-4225-BDAE-8883A372B359Q33298405-A2E2F03A-FB02-490D-A0AC-1635E71CF801Q34009739-154F90CA-3566-4B57-9355-118C6E3859F6Q35054493-3DB2D4F4-398E-4875-A53D-45CC0460FD67Q35176262-CE90589C-993B-4FA4-A3E7-48723692DD6DQ35850904-06A761B5-7104-4084-BDEC-68EB32E3FC10Q36008865-0ACFC852-076F-4486-BF23-BA3834E4E3A9Q36516810-82915A7E-8649-41FB-9AAD-16A3FC36AA21Q38066467-069A018E-E358-4B5B-99F2-9CE4899E72B7Q38092832-537D164E-68AA-4FEA-AEB6-E19E07D63A77Q39137793-715E24F2-049B-4EA2-90EF-1E174C06C68DQ39283041-B7665179-E03B-49F6-91E7-02AEDFFDEFCCQ42119300-E117A449-AC40-4C8F-8B83-EE8582929143Q42584975-A8366F76-72F3-46F1-B221-C6C05E99D004Q47614173-A94D3A1A-5FB1-4D2D-B461-9CFA0094A966Q51764702-446888F8-BE47-4EC8-A58F-88E1BA848027Q52358358-8898B865-B5F0-45A6-8D8F-45275551DE46Q53510154-D2651E20-1F88-45BF-9E55-6AB551008C93Q55248128-0E9AC3E7-CE6D-4535-8E57-2860D8E49BA2Q56610443-EDC3E39E-8ACD-4BE4-B9A8-E30025DCEE5CQ59127894-F3468900-5636-4531-B2E8-BADCF4B0E479Q59136382-8CCED8D5-EDEC-4339-A1F2-9E3C4FBC23AC
P2860
Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Serum amyloid P component boun ...... pathway complement activation
@en
type
label
Serum amyloid P component boun ...... pathway complement activation
@en
prefLabel
Serum amyloid P component boun ...... pathway complement activation
@en
P2093
P2860
P1476
Serum amyloid P component boun ...... pathway complement activation
@en
P2093
C J de Haas
E M van Leeuwen
K P van Kessel
T van Bommel
P2860
P304
P356
10.1128/IAI.68.4.1753-1759.2000
P407
P577
2000-04-01T00:00:00Z